Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

阅读量:

65

摘要:

Adiponectin, a plasma protein exclusively synthesized and secreted by adipose tissue, has recently been shown to have anti-inflammatory, antiatherogenic properties in vitro and beneficial metabolic effects in animals. Lower plasma levels of adiponectin have been documented in human subjects with metabolic syndrome and coronary artery disease. We investigated whether the level of this putative protective adipocytokine could be increased by treatment with a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist in diabetic patients.

展开

DOI:

10.2337/diacare.25.2.376

被引量:

1183

年份:

2002

相似文献

参考文献

引证文献

来源期刊

引用走势

2004
被引量:113

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用